Thomas Rodgers

4PUBLICATIONS
22CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsTumour immunology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

|Oct 26, 2020
Toxicity patterns of novel PI3K combinations in patients with non-Hodgkin lymphoma.

Thomas D Rodgers, AnnaLynn M Williams, Andrea Baran

|Mar 22, 2020
Assessment of the Efficacy of Therapies Following Venetoclax Discontinuation in CLL Reveals BTK Inhibition as an Effective Strategy.

Anthony R Mato, Lindsey E Roeker, Ryan Jacobs

|Dec 18, 2019
Efficacy of lenalidomide in high-risk diffuse large B-cell lymphoma.

Thomas D Rodgers, Andrea Baran, Patrick M Reagan

Pageof 1